Seeking Alpha

Disc Medicine, Inc. (IRON) Presents at Stifel 2025 Healthcare Conference Transcript

Yes. Just thank you very much for having us here again this year, especially at such an exciting time in the company's growth. I feel like every year, we're saying, it's an incredible time for the ...
Seeking Alpha

Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

WATERTOWN, Mass., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Nasdaq

Disc Medicine to Host Conference Call on FDA Feedback for Bitopertin Development in Erythropoietic Protoporphyria

Disc Medicine, Inc. will hold a conference call on January 21, 2025, at 8:00 am EST to discuss feedback from the FDA regarding its investigational drug, bitopertin, for treating Erythropoietic ...
Morningstar

Twin Disc Announces Details of Fiscal 2025 Fourth Quarter Earnings Release, Webcast, and Conference Call

MILWAUKEE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that it will release its fiscal 2025 fourth-quarter results at approximately 8:00 am Eastern on August 21, ...
Morningstar

Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

Please register for the event on the Events and Presentations page of Disc’s website at https://ir.discmedicine.com/. Bitopertin is an investigational, clinical ...